A non-randomized, open-label, single-dose, crossover study to evaluate the dose proportionality of the final fixed dose combination formulation of Coreg CR [carvedilol] and lisinopril.

Trial Profile

A non-randomized, open-label, single-dose, crossover study to evaluate the dose proportionality of the final fixed dose combination formulation of Coreg CR [carvedilol] and lisinopril.

Completed
Phase of Trial: Phase I

Latest Information Update: 14 Oct 2010

At a glance

  • Drugs Carvedilol/lisinopril (Primary)
  • Indications Hypertension
  • Focus Pharmacokinetics
  • Sponsors GlaxoSmithKline
  • Most Recent Events

    • 14 Oct 2010 Last checked against ClinicalTrials.gov record.
    • 21 Apr 2008 Status changed from recruiting to completed according to ClinicalTrials.gov.
    • 12 Nov 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top